Alliance Pharma cuts sales guidance
26th May 2011 13:34
Shares in pharmaceutical company Alliance Pharma fell back on Thursday - despite a positive first four months of the year - after it cut its sales guidance of its enteric-coated prednisolone product. As previously reported, the group had warned that it is facing generic competition in relation to D
Read moreThursday tips round-up: Ferrexpo, Carnival, Petropavlovsk
24th Mar 2011 06:34
If you think we've got problems, try living in Ukraine. Inflation was running at 21 per cent there last year, a headache for companies such as Ferrexpo, which mines iron ore and ships it by rail and barge to its customers, mostly in Central and Eastern Europe. The shares are on about seven times thi
Read moreAcquisition strategy boosts Alliance
23rd Mar 2011 18:27
Speciality pharmaceuticals supplier Alliance Pharma continues to reap the benefits of its acquisition strategy and it is acquiring two more products from Reckitt Benckiser (RB). AIM-quoted Alliance specialises in acquiring existing drugs with a solid market base. They do not need a lot of money sp
Read moreSmall caps round-up: Flybe, Alliance Pharma, Roxi Petroleum...
12th Jan 2011 10:53
Last month's snow has cost no-frills regional airline Flybe about £6m in lost revenue on cancelled flights and cost for delays, diversions and additional de-icing. The company, which floated in London in December, said almost 2,000 flights were cancelled - 16% of the planned flying programme - alth
Read moreBroker tips: Sage, Alliance Pharma, JJB Sports
2nd Dec 2010 12:47
Sage's subscription revenue growth has led Nomura to expect solid execution next year from the blue chip accountancy software firm. Sage reported "robust subscription revenues growing at 3%" in the second half versus the broker's expectation of 1%. Nomura notes that a growth of around 4% is achieva
Read moreBroker snap: Cost-effective growth for Alliance Pharma
2nd Dec 2010 12:26
Low operating costs and high margins has led finnCap to initiate a 'buy' recommendation for Alliance Pharma as the readily scalable and profitable business has the potential to add to its product portfolio. The pharmaceutical company's portfolio of products provide gross margins of over 55% and the
Read moreThursday tips round-up: Thornton's, Lupus Capital, Alliance Pharma
9th Sep 2010 06:50
Chocolate firm Thornton's shares are a perennial underperformer, above £2 in May 2007 but now, at 81½p, lower than they were at the start of 2009. The problem, as was made clear in May's profit warning, is the high street chain. Commercial sales in the first half to the end of June, that is, chocola
Read moreLondon close: US spurs Footsie recovery
8th Sep 2010 16:36
Footsie put its weak start behind it to close with good gains, helped by buoyant trading on Wall Street. US shares recovered from losses yesterday that snapped a recent winning streak. Among the risers here was ARM Holdings. UBS has issued a downbeat assessment of the European semiconductor mark
Read moreLondon afternoon: ARM in line for Samsung boost
8th Sep 2010 14:28
Footsie emerged from the lunch-time session nursing a small gain, with the majority of the blue-chip index's constituents in positive territory. Chief among them was chip designer ARM Holdings. UBS has issued a downbeat assessment of the European semiconductor market but it has made an exception o
Read moreLondon midday: BP spreads the blame
8th Sep 2010 12:00
It's back to square one for London with the Footsie virtually unchanged at the end of the morning session after early losses were wiped out. News that the US markets look set to open firmer after yesterday's triple-digit fall for the Dow has bolstered confidence this side of the pond. BP edged high
Read moreLondon open: Dull start for blue chips
8th Sep 2010 08:45
Last night's triple-digit drop on Wall Street and further losses in Asia meant a poor start in London. US stocks fell on concerns about the European bank stress tests. Property groups are the best performers with Land Securities, Hammerson and British Land all rising strongly. A potential politic
Read moreRecord results at Alliance Pharma
8th Sep 2010 08:23
Alliance Pharma said it would more than double its interim dividend as it posted record results during the first half. For the six months to the end of June profit before tax and exceptional items surged to £7.7m. Sales rose 77% to £23.4m. Operating profit before exceptional items increased 123% to
Read moreSmall caps round-up: Ithaca, Ambrian Capital, Providence...
6th Jul 2010 12:07
Oil and gas firm Ithaca Energy said it increased production throughout the second quarter of 2010 and remains on target to achieve forecast 2010 production levels. Production in the second quarter averaged 10,217 barrels of oil per day, a 17% improvement over first quarter production. Stockbroker
Read moreAlliance Pharma Trading Continues To Be Strong, Sales Up By 40%
6th Jul 2010 07:25
LONDON (Dow Jones)--Alliance Pharma PLC (APH.LN), a specialty pharmaceutical company, said Tuesday trading continues to be strong with sales for the six months ended June 30 of GBP23.4 million, an increase of GBP10.2 million on the first half of 2009. MAIN FACTS: -Excluding revenue from prod
Read moreC&W Worldwide boss adds to holding
29th Mar 2010 16:31
Chief executive Jim Marsh has been buying shares in Cable & Wireless Worldwide following its demerger from Cable & Wireless Communications last week. He bought 43,500 shares at 94.27p each on Friday and 203,000 at 91.8p each on Monday. The total investment was just over £227,000. Marsh owns 651,
Read more